Fidelity Investments’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $37.7K | Sell |
|
|||||
|
2025
Q1 | $65.7K | Sell |
|
|||||
|
2024
Q4 | $22.4M | Sell |
|
|||||
|
2024
Q3 | $38.1M | Sell |
|
|||||
|
2024
Q2 | $63.2M | Sell |
|
|||||
|
2024
Q1 | $110M | Buy |
|
|||||
|
2023
Q4 | $119M | Sell |
|
|||||
|
2023
Q3 | $158M | Sell |
|
|||||
|
2023
Q2 | $413M | Buy |
|
|||||
|
2023
Q1 | $297M | Buy |
|
|||||
|
2022
Q4 | $250M | Buy |
|
|||||
|
2022
Q3 | $247M | Buy |
|
|||||
|
2022
Q2 | $193M | Buy |
|
|||||
|
2022
Q1 | $186M | Buy |
|
|||||
|
2021
Q4 | $234M | Sell |
|
|||||
|
2021
Q3 | $250M | Sell |
|
|||||
|
2021
Q2 | $390M | Sell |
|
|||||
|
2021
Q1 | $655M | Buy |
|
|||||
|
2020
Q4 | $675M | Buy |
|
|||||
|
2020
Q3 | $477M | Buy |
|
|||||
|
2020
Q2 | $324M | Buy |
|
|||||
|
2020
Q1 | $224M | Buy |
|
|||||
|
2019
Q4 | $561M | Buy |
|
|||||
|
2019
Q3 | $1.09B | Buy |
|
|||||
|
2019
Q2 | $1.4B | Buy |
|
|||||
|
2019
Q1 | $1.21B | Buy |
|
|||||
|
2018
Q4 | $674M | Buy |
|
|||||
|
2018
Q3 | $989M | Buy |
|
|||||
|
2018
Q2 | $1.09B | Buy |
|
|||||
|
2018
Q1 | $1.11B | Buy |
|
|||||
|
2017
Q4 | $1.03B | Buy |
|
|||||
|
2017
Q3 | $350M | Buy |
|
|||||
|
2017
Q2 | $446M | Buy |
|
|||||
|
2017
Q1 | $397M | Buy |
|
|||||
|
2016
Q4 | $285M | Buy |
|
|||||
|
2016
Q3 | $252M | Buy |
|
|||||
|
2016
Q2 | $145M | Buy |
|
|||||
|
2016
Q1 | $154M | Buy |
|
|||||
|
2015
Q4 | $252M | Buy |
|
|||||
|
2015
Q3 | $183M | Buy |
|
|||||
|
2015
Q2 | $311M | Buy |
|
|||||
|
2015
Q1 | $194M | Buy |
|
|||||
|
2014
Q4 | $142M | Buy |
|
|||||
|
2014
Q3 | $121M | Buy |
|